openPR Logo
Press release

Artificial Intelligence (AI) in Healthcare Market: Research Report Overview by Industry Size, Share, Trends, Growth & Leading Players (2018-2025)

Artificial intelligence in healthcare market

Artificial intelligence in healthcare market

Research report presented by UnivDatos, Emphasis on Technology (Machine Learning, Deep Learning, Artificial Neural Network), Applications (Robotic Surgery, Diagnosis, Virtual Nursing Assistance, Administrative Workflow Assistance); Offerings (Hardware, Software and Services) and Geographical analysis (key regions and countries).

As per the research report, Artificial Intelligence (AI) in healthcare market is expected to reach the market value of US$ 26.6 billion by 2025, growing at a CAGR of 41% during the forecast period (2018-2025). Artificial Intelligence (AI) is expected to contribute up to US$ 15.7 trillion to global GDP by 2030. AI applications, powered by an influx of big data and advancements in computing power, are positioned to transform major sectors, including healthcare. Global expenditures on healthcare increased to 9.9% of the total GDP in 2017, up from 8.6% in 2000. The United States witnessed the highest expenditure on healthcare, 17% of total GDP, in 2017. The world's population, aged 60 years and above, is likely to grow by 56% from 2015 to 2030. The healthcare industry is expected to benefit from US$ 45 billion in annual cost savings by 2025.

For complete research, request for Sample of the report browse through – https://univdatos.com/request_form/form/157

Healthcare is one of the largest and most rapidly growing segments of AI, driven predominantly by innovation in clinical research, robotic personal assistants and big data analytics. Healthcare is poised to accelerate investments in AI over the next few years. On an estimate, artificial intelligence in healthcare raised a record US$ 4 billion in 2019, up from nearly US$ 2.7 billion in 2018 with a total of 367 and 264 investment deals respectively.

COVID-19 Impact

To tackle and look forward to emerging diseases, healthcare delivery includes the assistance of new technology such as Artificial Intelligence (AI), Internet of Things ( IoT), Big Data, and machine learning. Some of the major applications of AI during the COVID-19 pandemic include early detection and diagnosis of the infection, treatment monitoring, contact tracing, projection of cases and mortality, development of drugs and vaccines, reducing the workload of healthcare workers, among others. For instance: In China, Alibaba has developed an AI algorithm that can diagnose suspected COVID-19 cases within 20 seconds (almost 45 times faster than the conventional approach) with 96% accuracy.

For detailed analysis on the segmentation in Global Artificial Intelligence (AI) in Healthcare browse Market through https://univdatos.com/report/global-market-insights-on-ai-in-healthcare

Artificial Intelligence (AI) in Healthcare Market report is studied thoroughly with numerous aspects that would help stakeholders in making a curated decision.

By Technology, the market is primarily bifurcated into

Machine learning

Dep learning

Intelligent agent

Neural networks

Machine Learning dominated the technology segment of Artificial Intelligence (AI) in healthcare market. In 2019, machine learning accounted for almost 39% of the market share and is expected to grow at a CAGR of 41.2% over the forecast period. Machine learning in healthcare has its ability to process huge datasets beyond the limits of human capacity and then efficiently turn the interpretation of that data into clinical insights that help doctors in planning and delivering care, eventually leading to better results at lower care costs.

For detailed analysis on the opportunities in Global Artificial Intelligence (AI) in Healthcare Market browse through https://univdatos.com/report/global-market-insights-on-ai-in-healthcare

By Application, the market is primarily segmented into

Robotic surgery

Diagnosis

Virtual Nursing assistance

Administrative workflow assistance

Advances analytics and research

In 2019, robotic surgery dominated Artificial Intelligence (AI) in healthcare market with 35% of the market share. Robotic surgery, or robot-assisted surgery, allows doctors to perform several complex procedures with more precision, flexibility, and control than is possible with conventional techniques.

By Offering, the market is primarily fragmented into

Hardware

Software

Services

In 2019, services dominated the artificial intelligence (AI) in healthcare market with 76% of the market share and is expected to remain dominant over the forecast period, as AI services can support healthcare professionals with faster service, early diagnosis, and data analysis to identify required information to save someone from a particular disease.

For detailed analysis on the major applications in Global Artificial Intelligence (AI) in Healthcare Market browse through https://univdatos.com/report/global-market-insights-on-ai-in-healthcare

Artificial Intelligence (AI) in Healthcare Market Geographical Segmentation Includes:

North America

Europe

Asia-Pacific

Rest of the world

Based on the estimation, North America dominated Artificial Intelligence (AI) in healthcare market with nearly 45% of the market share in 2019. However, Asia-Pacific is expected to grow at the highest CAGR over the analyzed period due to the rising incidence of chronic diseases, a huge population base, limited number of healthcare professionals. Witnessing such factors, the region offers lucrative opportunities for AI healthcare providers to capitalize significantly.

The major players targeting the market includes

Medtronic Plc

Abbott Laboratories

Johnson and Johnson

Becton Dickinson

Boston Scientific Corporation

Koninklijke Philips N.V

Roche Holding AG

Siemens Healthineers AG

Stryker Corporation

Oracle Corporation

The competitive landscape has been provided pointing out the position of the key market players in the market along with the market share that is held by major players. These players are constantly working on expanding the market reach through M&A's along with partnerships.

The Artificial intelligence in healthcare market can be customized to the country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.

Contact us:
UnivDatos Market Insights (UMI)
Email: sales@univdatos.com
Web: https://univdatos.com
Ph: +91 7838604911

About Us:
UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI) in Healthcare Market: Research Report Overview by Industry Size, Share, Trends, Growth & Leading Players (2018-2025) here

News-ID: 2292659 • Views: 681

More Releases from UnivDatos Market Insights (UMI)

Active Pharmaceutical Ingredient Market - Comprehensive Insights by Demand Statu …
Global active pharmaceutical ingredient market is expected to witness a CAGR of around 6% during the forecast period. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some drugs have multiple active pharmaceutical ingredients. The rising prevalence of the various diseases coupled with the COVID-19 pandemic is expected to drive the market for active pharmaceutical ingredients. Furthermore, the surging investments in research and
Automotive Data Logger Market: Research Strategies with Share Analysis, Top Key …
Modern car data loggers are more expensive than traditional OBD-I systems. However, data loggers that simply support CAN and LIN channels are less expensive than those that handle all of the major channels (CAN, LIN, FlexRay, and Ethernet). This is also dependent on the amount of analog and digital inputs that data loggers can accommodate. OEMs are always pressuring data logger vendors to reduce device pricing while preserving device quality.
Microbiology Culture Market: Research Strategies with Share Analysis, Top Key Pl …
There has been an increase in the global market for microbial culture due to the rise in antibiotic demand owing to the rise in infectious diseases such as HIV/AIDS, Tuberculosis, and Viral Hepatitis. For instance, as per the CDC, in the United States around 7,100 number are reported Tuberculosis (TB) in 2020 (a rate of 2.2 per 100,000 persons) which increased to around 7,800 number is reported TB cases in
Rising Awareness of Better Aesthetic Treatments is Expected to Drive the Market …
Laser hair removal is one of the most common hair removal techniques in many countries. In this procedure, hair is removed by the action of a laser on the hair follicle. The pigment in the follicle absorbs the laser and destroys the hair, the damage to the hair follicle also restricts further growth. This technique is also being used to remove hairs on different hair-related medical conditions such as Hirsutism,

All 5 Releases


More Releases for Artificial

Artificial Paintings Releases NFT
Artificial Paintings - a tech company that trained AI to create works of digital art - has transformed its AI-driven digital paintings into NFTs. The company has already presented more than a hundred of NFTs and plans to keep releasing more. An NFT (non-fungible token) is a unique piece of digital artwork stored on a digital ledger. Non-fungible means that the digital asset is not interchangeable. In 2021, the NFT
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New
Artificial intelligence for industrial microbiology
Munich, Germany, November 23, 2017 - vermicon AG, the specialist for microbiological solutions, is launching the new Scan VIT® system for analysis of microorganisms. It is able to quantify and specifically identify single cells directly and without time-consuming enrichment steps. A fully automated analysis evaluation is provided by the intelligent VIT® Vision software, which is the centerpiece of the new, patented technology. In contrast to conventional rapid test methods, the
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells.  For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard and
Global Artificial Intelligence Market
According to a new report, Global Artificial Intelligence Market (2016-2022), published by KBV Research, the global artificial intelligence market is estimated to reach USD 16,274.0 Million by 2022, at a CAGR of 44.5% from 2016 to 2022. The North America market dominated the Global Artificial Intelligence Market in 2015, and would continue to be a dominant market till 2022; thereby growing at a CAGR of 42.7% during the forecast period.